youtube_live
Q3 2026 earnings • 12:00 AM today
See detailschevron_right
EW:NYSE
Edwards Lifesciences Corp
US$99.37
arrow_upward
+4.38%(+4.17) 1D
US$101.88
arrow_upward
+2.53% (+2.51)bedtimeAfter hours
Closed: ኖቬም 4, 4:00:04 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
US$98.58
High
US$100.25
Low
US$96.72
Mkt. cap
57.28 ቢ
Avg. vol.
4.00 ሚ
Volume
7.88 ሚ
P/E ratio
57.49
52-wk high
US$100.25
52-wk low
US$74.66
EPS
US$1.73
Beta
0.85
Shares outstanding
576.40 ሚ
No. of employees
16 ሺ
Open
US$98.58
High
US$100.25
Low
US$96.72
Mkt. cap
57.28 ቢ
Avg. vol.
4.00 ሚ
Volume
7.88 ሚ
P/E ratio
57.49
52-wk high
US$100.25
52-wk low
US$74.66
EPS
US$1.73
Beta
0.85
Shares outstanding
576.40 ሚ
No. of employees
16 ሺ
News stories
From web sources and news partners
Benzinga
·
ከ19 ደቂቃዎች በፊት
Edwards Lifesciences Q3 2026 Earnings Call Transcript
GuruFocus
·
ከ1 ሰዓት በፊት
Edwards Lifesciences Reports Q3 2026 Earnings: Revenue of $1.72
TradingView
·
ከ1 ሰዓት በፊት
Edwards Lifesciences Q3 2026 Earnings Call Is Live
Investing.com
·
ከ1 ሰዓት በፊት
Edwards Lifesciences earnings beat by $0.06, revenue topped estimates
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 ሺ
Founded1958
Headquartersኢርቪን, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorMedical device
Industry-
Websiteedwards.com